C12Y 301/01001
Carboxylesterase
Official title: Carboxylesterase (3.1.1.1)
C12Y301/01001 (Carboxylesterase) appears on 57 US grants and 100 published applications in this corpus.
Search patents in C12Y- Granted patents
- 57
- Published applications
- 100
- Assignees
- 66
- Inventors
- 276
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 2 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 1 | 1 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 2 |
| 2010 | 0 | 6 |
| 2011 | 3 | 11 |
| 2012 | 10 | 7 |
| 2013 | 5 | 5 |
| 2014 | 1 | 2 |
| 2015 | 2 | 5 |
| 2016 | 6 | 6 |
| 2017 | 4 | 1 |
| 2018 | 1 | 4 |
| 2019 | 1 | 4 |
| 2020 | 5 | 5 |
| 2021 | 4 | 10 |
| 2022 | 1 | 6 |
| 2023 | 2 | 5 |
| 2024 | 3 | 6 |
| 2025 | 4 | 7 |
| 2026 | 3 | 4 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Bacillus cell with reduced lipase and/or esterase side activities8 Sep 2026US 12,729,391 B2BASF SE
- Degradable bio-based polymers11 Aug 2026US 12,703,768 B2Algenesis Corporation
- Device for detecting organophosphates24 Feb 2026US 12,559,735 B2PlantVax, Inc.
- Method for enzymatically producing maytansinol18 Nov 2025US 12,473,579 B2Microbiopharm Japan Co., Ltd.
- Carboxyesterase biocatalysts17 Jun 2025US 12,331,327 B2GlaxoSmithKline Intellectual Property Development Limited
- Novel fumonisin degradation enzyme and use thereof30 Jul 2026US 2026/0218141 A1Cj Cheiljedang Corporation
- Means and Methods for Increased Protein Expression by Use of a Combination of Transport Proteins and Either Chaperones or Transcription Factors23 Jul 2026US 2026/0209783 A1Boehringer Ingelheim Rcv GmbH & Co KG
- Modified mammalian cells9 Apr 2026US 2026/0098254 A1Genentech, Inc.
- Extracellular Carboxylesterase 2 (CES2) for the Treatment of Metabolic Disease22 Jan 2026US 2026/0021165 A1The Board of Trustees of the Leland Stanford Junior University
- Method of making glycomonolipids30 Oct 2025US 2025/0333772 A1The Procter & Gamble Company
Most cited
By later US patents
- Esterases and uses thereof18US 10,590,401 B2Carbios · 2020
- Perhydrolases for enzymatic peracid generation18US 8,062,875 B2E. I. du Pont de Nemous and Company · 2011
- Esterases and uses thereof17US 11,072,784 B2Carbios · 2021
- Stabilization of perhydrolases10US 8,030,038 B2E. I. Du Pont de Nemours and Company · 2011
- Enzymatic generation of functional lipids from cereals or cereal bi-streams6US 9,370,193 B2Dupont Nutrition Biosciences Aps · 2016